Strides Pharma Science Limited

Strides Pharma Science Limited

Strides Pharma Science Limited has submitted its Business Responsibility and Sustainability Report for FY 2026, as per SEBI regulations.

Strides Pharma Science Limited

Strides Pharma Science Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 14, 2026. The meeting will be held through Video Conference/ Other Audio-Visual Means (VC/ OAVM) and will consider the Audited Financial Statements for FY2025-26.

Strides Pharma Science Limited

Strides Pharma Science Limited has announced the record date for its final dividend as July 31, 2026, and has scheduled its 35th Annual General Meeting for August 14, 2026.

Strides Pharma Science Limited

Strides Pharma Science Limited has informed the Exchange about Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosing certificates received from KFin Technologies Limited for the quarter ended June 30, 2026.

Strides Pharma Science Limited

Strides Pharma Science Limited has completed the sale of its majority stake in Pivot Path to a consortium led by Ascent Capital for ₹1,000 million, with ₹750 million received and the balance of ₹250 million payable on the first anniversary of the closing date.